Results 51 to 60 of about 15,328 (206)
An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients
Transplant Infectious Disease, EarlyView.ABSTRACT Invasive fungal infections (IFI) remain a significant infection‐related complication in solid organ transplant recipients (SOTRs), the incidence of which has not changed overtime. With a focus on studies and data published after 2019, this narrative review provides an update on the epidemiology and prevention of IFIs in SOTRs and highlights ...
Tina Marinelli, Shahid Husain
wiley +1 more source
, 2021 BACKGROUND The human pathogen Pneumocystis jirovecii harbors six families of major surface glycoproteins (MSG) encoded by a single gene superfamily. MSGs are presumably responsible for antigenic variation and adhesion to host cells.
Richard, Sophie +11 more
core +1 more source
Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report
Medical Mycology Case Reports, 2018 The highest risk of opportunistic infections is from 1 to 6 months post-transplant. We report a rare case of Pneumocystis jirovecii pneumonia in a renal transplant recipient only on maintenance immunosuppression eleven years after transplant without ...
Prithiv Prasad +2 more
doaj +1 more source
Journal of Fungi, 2020 Pneumocystis pneumonia (PcP) is a disease produced by the opportunistic infection of the fungus Pneumocystis jirovecii. As delayed or unsuitable treatments increase the risk of mortality, the development of rapid and accurate diagnostic tools for PcP are
Luis Pla +9 more
doaj +1 more source
Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
Current Oncology, 2021 An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia.
Jérémy Barben +4 more
doaj +1 more source
Bridging the Gap Between General and Transplant Infectious Disease Practice
Transplant Infectious Disease, EarlyView.ABSTRACT The population of iatrogenic immunocompromised individuals is steadily rising as we continue to improve in our ability to manage diseases, including cancer, autoimmune disease, and end‐organ dysfunction, with increasing access to novel agents and transplantation.
Jeremey Walker +4 more
wiley +1 more source
Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population
Frontiers in Public Health, 2019 Objective:Pneumocystis pneumonia remains a major opportunistic infection in immunocompromised patients worldwide. Colonization with Pneumocystis jirovecii has recently gained attention as an important issue for understanding the complete cycle of human ...
Rubén Morilla +12 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.In a retrospective cohort study of 149 patients receiving atovaquone for PJP prophylaxis, increased usage was related to broader indications, uptake in new patient groups, difficulty tolerating or accessing alternatives, and longer durations used per patient.
To N. Pham +5 more
wiley +1 more source
, 2010 Jose G Castro1, Maya Morrison-Bryant21Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA; 2Jackson Memorial Hospital/University of Miami Infectious Diseases Fellowship Program, Miami, Florida, USAAbstract:
null Morrison-Bryant +5 more
core +2 more sources
Identification of B-cell and T-cell specific peptide vaccine for Pneumocystis jirovecii
, 2023 Pneumocystis jirovecii is a fungal pathogen that causes a severe lung infection primarily in individuals with compromised immune systems. The high morbidity and mortality associated with Pneumocystis jirovecii pneumonia (PJP) highlight the need for ...
Sumedha Balaji , Sathish Sankar
core +2 more sources